In what could be a major setback for drugmakers Hoffmann-La Roche and GlaxoSmithKline, their medicines namely Tamiflu and Relenza respectively, are once again under scanner with the researchers doubting their credibility. According to the researchers, the governments are wasting billions of dollars on the drugs whose effectiveness is in doubt. During a review of trial data on Tamiflu and … [Read more...]
Tamiflu saved lives of people during 2009 H1N1 flu pandemic: Roche-backed study
A new study has found the scientific evidences in the role played by antiviral drug Tamiflu in saving lives of people affected during the 2009 H1N1 swine flu pandemic. According to the study, the medicine reduced the risk of H1N1 deaths by 25 percent. The study also found that the cases in which the antiviral treatment were taken within 48 hours of developing flu symptoms, the risk of death was … [Read more...]
